ESC/EASD Joint Guidelines on Diabetes and Cardiovascular Diseases

被引:0
|
作者
Motz, Wolfgang [1 ]
Doerr, Rolf [2 ]
机构
[1] Klin Grp Dr Guth GmbH & Co KG, Klinikum Karlsburg, D-17495 Karlsburg, Germany
[2] Akad Lehrpraxisklin TU, Praxisklin Herz & Gefasse Kardiol Angiol Radiol N, Dresden, Germany
关键词
Diabetes mellitus; Prediabetes; Cardiovascular diseases; Coronary heart disease; Coronary artery disease equivalent; Risk factors; Coronary revascularization; CORONARY-HEART-DISEASE; DRUG-ELUTING STENTS; ELEVATION MYOCARDIAL-INFARCTION; SUDDEN CARDIAC DEATH; BLOOD-PRESSURE; CLINICAL-OUTCOMES; GLUCOSE-TOLERANCE; RISK-FACTORS; FOLLOW-UP; MELLITUS;
D O I
10.1007/s00059-009-3203-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The ESC/EASD (European Society of Cardiology/European Association for the Study of Diabetes) joint Guidelines on diabetes, pre-diabetes, and cardiovascular diseases have, for the first time, addressed diabetes mellitus and cardiovascular diseases (CVD) as a pathophysiological entity in Europe. Based on these guidelines, diabetes mellitus is regarded from the outset to be a cardiovascular disease, whose life-threatening complications myocardial infarction and stroke can only be avoided by an interdisciplinary concerted action. The most important information of these guidelines for the interdisciplinary cooperation of primary-care physicians, diabetologists and cardiologists are the postulations that patients with the main diagnosis diabetes mellitus with or without known CVD should, at regular intervals, be referred to a cardiologist, and patients with the main diagnosis CVD with or without diabetes mellitus should, at regular intervals, be referred to a diabetologist. Of fundamental importance is the prevention of diabetes and CVD by a comprehensive lifestyle modification including smoking cessation, regular physical activity and weight control, flanked by an evidence-based drug therapy. Within the framework of a multimodal risk management, an optimal antihypertensive therapy of a concomitant elevated blood pressure; a statin therapy in case of elevated LDL cholesterol or regardless of an elevated LDL in proven CVD; ACE inhibitors, angiotensin II receptor blockers, or beta-blockers in case of heart failure; and an anticoagulant therapy for the prevention of cardioembolic stroke in patients with atrial fibrillation all have class I recommendations. Concerning the preferred coronary revascularization procedure in diabetics, today no rigid general recommendation can be given in favor of or against coronary bypass surgery, or in favor of or against percutaneous coronary intervention. The decision for a specific revascularization procedure should, in any case, be based on a detailed analysis of the individual coronary anatomy.
引用
收藏
页码:21 / 29
页数:9
相关论文
共 50 条
  • [41] Validity of a multidimensional comprehensive psychosocial screening instrument based on the ESC cardiovascular prevention guidelines-Evidence from the general and cardiovascular patient population
    van den Houdt, Sophie
    Albus, Christian
    Herrmann-Lingen, Christoph
    Widdershoven, Jos
    Kupper, Nina
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 2022, 157
  • [42] Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1.9 million people
    Shah, Anoop Dinesh
    Langenberg, Claudia
    Rapsomaniki, Eleni
    Denaxas, Spiros
    Pujades-Rodriguez, Mar
    Gale, Chris P.
    Deanfield, John
    Smeeth, Liam
    Timmis, Adam
    Hemingway, Harry
    LANCET DIABETES & ENDOCRINOLOGY, 2015, 3 (02) : 105 - 113
  • [43] Overweight, cardiovascular diseases and diabetes Health in Sweden: The National Public Health Report 2012
    Norberg, Margareta
    Danielsson, Maria
    SCANDINAVIAN JOURNAL OF PUBLIC HEALTH, 2012, 40 : 135 - 163
  • [44] Evaluation of a Community-Based Cardiovascular Prevention Program in Patients With Type 2 Diabetes
    Finn, Yvonne
    Gorecka, Miroslawa
    Flaherty, Gerard
    Dunne, Fidelma
    O'Brien, Timothy
    Crowley, James
    Wood, David
    Connolly, Susan
    Jones, Jennifer
    Gibson, Irene
    AMERICAN JOURNAL OF HEALTH PROMOTION, 2020, : 68 - 76
  • [45] Effect of tight control of HbA1c and blood pressure on cardiovascular diseases in type 2 diabetes: An observational study from the Swedish National Diabetes Register (NDR)
    Cederholm, Jan
    Zethelius, Bjorn
    Nilsson, Peter M.
    Eeg-Olofsson, Katarina
    Eliasson, Bjorn
    Gudbjornsdottir, Soffia
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2009, 86 (01) : 74 - 81
  • [46] Cardiovascular Prevention in Clinical Practice (ESC and German Guidelines 2007)
    Gohlke, Helmut
    Albus, Christian
    Gysan, Detlef Bernd
    Hahmann, Harry W.
    Mathes, Peter
    HERZ, 2009, 34 (01) : 4 - 14
  • [47] 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk
    Mach, Francois
    Baigent, Colin
    Catapano, Alberico L.
    Koskina, Konstantinos C.
    Casula, Manuela
    Badimon, Lina
    Chapman, M. John
    De Backer, Guy G.
    Delgado, Victoria
    Ference, Brian A.
    Graham, Ian M.
    Halliday, Alison
    Landmesser, Ulf
    Mihaylova, Borislava
    Pedersen, Terje R.
    Riccardi, Gabriele
    Richter, Dimitrios J.
    Sabatine, Marc S.
    Taskinen, Marja-Riitta
    Tokgozoglu, Lale
    Wiklund, Olov
    Windecker, Stephan
    Aboyans, Victor
    Baigent, Colin
    Collet, Jean-Philippe
    Dean, Veronica
    Delgado, Victoria
    Fitzsimons, Donna
    Gale, Chris P.
    Grobbee, Diederick
    Halvorsen, Sigrun
    Hindricks, Gerhard
    Iung, Bernard
    Juni, Peter
    Katus, Hugo A.
    Leclercq, Christophe
    Lettino, Maddalena
    Lewis, Basil S.
    Merkely, Bela
    Mueller, Christian
    Petersen, Steffen
    Petronio, Anna Sonia
    Roffi, Marco
    Shlyakhto, Evgeny
    Simpson, Iain A.
    Sousa-Uva, Miguel
    Touyz, Rhian M.
    Nibouche, Djamaleddine
    Zelveian, Parounak H.
    Siostrzonek, Peter
    ATHEROSCLEROSIS, 2019, 290 : 140 - 205
  • [48] Social Determinants of Health and Disparities in Hypertension and Cardiovascular Diseases
    Chaturvedi, Abhishek
    Zhu, Anqi
    Gadela, Naga Vaishnavi
    Prabhakaran, Dorairaj
    Jafar, Tazeen H.
    HYPERTENSION, 2024, 81 (03) : 387 - 399
  • [49] Risk factors for cardiovascular diseases: the focus on primary prevention
    Wolska, Magdalena
    Peruzzi, Mariangela
    Kazirod-wolski, Karol
    Wrobel, Pawel
    Oles, Izabela
    Sielski, Janusz
    Jankowski, Piotr
    MINERVA CARDIOLOGY AND ANGIOLOGY, 2023, : 245 - 253
  • [50] Risk factors for cardiovascular diseases. Bibliographic review
    Mejia-Montilla, Jorly
    Reyna-Villasmil, Nadia
    Bravo-Henriquez, Alfonso
    Fernandez-Ramirez, Andreina
    Reyna-Villasmil, Eduardo
    AVANCES EN BIOMEDICINA, 2020, 9 (01) : 3 - 15